Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/ACI.0000000000000766 http://scihub22266oqcxt.onion/10.1097/ACI.0000000000000766 34269742!9914169!34269742     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34269742.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Opin+Allergy+Clin+Immunol 2021 ; 21 (5): 500-506 Nephropedia Template TP {{tp|p=34269742|t=2021. The effects of the COVID-19 pandemic on the treatment of allergic eye diseases |pdf=|usr=}}{{34269742}} gab.com Text The effects of the COVID-19 pandemic on the treatment of allergic eye diseases JO: Curr Opin Allergy Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34269742 #FOAvip PURPOSE OF REVIEW: To analyze if recommendations given before and during the COVID-19 pandemic are still a valid option for patients suffering of ocular allergy (OA). RECENT FINDINGS: During the last year many doctors and patients requested suggestions for the treatment of OA patients in COVID-19 time. Most of them were given by phone calls and emails following the recommendations given by Scientific Societies. SUMMARY: Considering the current multiple problems related to the COVID-19 pandemic, OA has not been considered a priority, even though patients need treatments. Topical antiallergic drugs are still the first option to treat all kind of OA, with the addition of topical corticosteroids in the severe forms of vernal and atopic keratoconjunctivitis (VKC and AKC) even in patients at risk of COVID-19. Topical immunomodulation is still recommended in severe forms of VKC and AKC unless the patient is infected. The number of patients treated with these drugs in our Center was similar than previous years. The risk to have a VKC patient affected by COVID-19 is similar to the general pediatric population but with a lower OR. In 2021, still in COVID-time, the management of OA should follow the previous recommendations with an update due to the risk of infection. Twit Text FOAVip The effects of the COVID-19 pandemic on the treatment of allergic eye diseases ????Curr Opin Allergy Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34269742 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34269742 #FOAvip English Wikipedia <ref>{{Cite pmid|34269742}}</ref> The effects of the COVID-19 pandemic on the treatment of allergic eye diseases #MMPMID34269742 Leonardi A; Salami E; Feuerman OM; Cavarzeran F Curr Opin Allergy Clin Immunol 2021[Oct]; 21 (5): 500-506 PMID34269742show ga PURPOSE OF REVIEW: To analyze if recommendations given before and during the COVID-19 pandemic are still a valid option for patients suffering of ocular allergy (OA). RECENT FINDINGS: During the last year many doctors and patients requested suggestions for the treatment of OA patients in COVID-19 time. Most of them were given by phone calls and emails following the recommendations given by Scientific Societies. SUMMARY: Considering the current multiple problems related to the COVID-19 pandemic, OA has not been considered a priority, even though patients need treatments. Topical antiallergic drugs are still the first option to treat all kind of OA, with the addition of topical corticosteroids in the severe forms of vernal and atopic keratoconjunctivitis (VKC and AKC) even in patients at risk of COVID-19. Topical immunomodulation is still recommended in severe forms of VKC and AKC unless the patient is infected. The number of patients treated with these drugs in our Center was similar than previous years. The risk to have a VKC patient affected by COVID-19 is similar to the general pediatric population but with a lower OR. In 2021, still in COVID-time, the management of OA should follow the previous recommendations with an update due to the risk of infection. |*Communicable Disease Control[MESH] |*Pandemics[MESH] |COVID-19/*epidemiology[MESH] |Conjunctivitis, Allergic/drug therapy/*therapy[MESH] |Eye Diseases/therapy[MESH] |Humans[MESH] |Hypersensitivity/therapy[MESH]The effects of the COVID-19 pandemic on the treatment of allergic eye (epmc).pdf DeepDyve Pubget Overpricing